Research and Markets has published the profiles of 550 new global venture capital firms. The new report features 550 Venture Capitalists in Canada, the United States, the United Kingdom and Germany.
It focuses on companies investing in: biotechnology, pharmaceuticals, medical devices/diagnostics, genomics, bioinformatics/bio-IT, health care and services
The report includes an online database of profiles featuring the contact information including multiple names, titles and e-mails, descriptions, preferred stage of investment, total capital under management, level of investment, geographic preference, and previous and/or current investments.